The company announced Bioma4me has implemented SOPHiA DDM™ to support its rare disorder testing capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced that Bioma4me, a Brazil-based company focused on genetic sequencing to drive precision medicine to the Brazilian […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days1, to include larger DNA preparations […]
EMERYVILLE, Calif. — Slingshot Biosciences Inc., a leader in the development of cell mimics for cell therapy, diagnostics, and rare disease research, is proud to announce the addition of Nicolas Barthelemy as its Executive Chair. “We have been working closely with Nicolas over the last two years and are excited to bring his experience, operational […]
MilliporeSigma announces a non-binding MoU with Mycenax Biotech to optimize bioprocessing production of life-changing biological therapies Integrates company‘s BioContinuum™ Platform in Mycenax’s Contract Development and Manufacturing Services (CDMO) for maximum safety, control, transparency, and repeatability Collaboration aims to enhance process intensification, advance towards BioProcessing 4.0 and continuous bioprocessing Burlington, Massachusetts – MilliporeSigma, the U.S. and Canada […]
SEATTLE — Eurofins Genomics, a global leader in sequencing services, announces the opening of a new, certified sequencing lab in Bothell, Washington, serving the greater Seattle area. The facility leverages the Oxford Nanopore’s sequencing platform and its local proximity to deliver results within 12 hours from sample pickup. The company has already lined up 30 partner labs in Seattle and conducting […]
New Haven, CT and Research Triangle Park, NC – AtlasXomics and EpiCypher announce their partnership to develop CUT&Tag kits and assay services for spatial epigenomics applications. These assays will be developed on AtlasXomics’ DBiT-seq platform using CUT&Tag reagents and antibodies from EpiCypher, expanding the spatial ‘omics toolbox to histone post translational modifications (PTMs), transcription factors, […]
In this role, Paul will lead the company’s global commercial strategy, drive business development initiatives, and play a pivotal role in fostering strategic partnerships. Paul Orange brings with him a wealth of experience in the bioprocessing industry, having held key leadership positions in various companies. His strategic vision, deep industry knowledge, and proven track record […]
CARLSBAD, Calif. Image: Overview: To help labs pursue more sustainable practices, Thermo Fisher Scientific has launched a next generation Invitrogen™ TaqMan™ Cells-to-CT™ Express Kit*, offering simplified, scalable workflows for gene expression analysis that produce less plastic waste. With improved chemistry, the Cells-to-CT Express Kit helps […]
Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived Organ-on-a-Chip solution for more accurate in vitro ADME predictions Early access to dual-organ model available through CN Bio’s Contract Research Services Cambridge, UK, and Durham, North Carolina, US: CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy […]
Redwood City, CA & Waltham, MA – Synthego, a leading provider of genome engineering solutions, and SeQure Dx, a company focused on off-target analysis for preclinical and clinical gene modification customers, have announced a strategic partnership to provide CRISPR-based therapeutics developers with comprehensive off-target editing analytical services that include best-in-class technology and turn-key end-to-end development solutions. […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
